These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 20667056)

  • 1. A multimarker approach for the prediction of coronary artery disease: cost-effectiveness analysis.
    Lakić D; Bogavac-Stanojević N; Jelić-Ivanović Z; Kotur-Stevuljević J; Spasić S; Kos M
    Value Health; 2010; 13(6):770-7. PubMed ID: 20667056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers.
    Bogavac-Stanojević N; Ivanova Petrova G; Jelić-Ivanović Z; Memon L; Spasić S
    Clin Biochem; 2007 Nov; 40(16-17):1180-7. PubMed ID: 17869234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incremental predictive value of vascular assessments combined with the Framingham Risk Score for prediction of coronary events in subjects of low-intermediate risk.
    Lau KK; Chan YH; Yiu KH; Tam S; Li SW; Lau CP; Tse HF
    Postgrad Med J; 2008 Mar; 84(989):153-7. PubMed ID: 18372487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid and inflammatory markers for the prediction of coronary artery disease: a multi-marker approach.
    Bogavac-Stanojević N; Jelić-Ivanović Z; Spasojević-Kalimanovska V; Spasić S; Kalimanovska-Ostrić D
    Clin Biochem; 2007 Sep; 40(13-14):1000-6. PubMed ID: 17632095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients.
    Kotur-Stevuljevic J; Memon L; Stefanovic A; Spasic S; Spasojevic-Kalimanovska V; Bogavac-Stanojevic N; Kalimanovska-Ostric D; Jelić-Ivanovic Z; Zunic G
    Clin Biochem; 2007 Feb; 40(3-4):181-7. PubMed ID: 17070511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct costs and cost-effectiveness of dual-source computed tomography and invasive coronary angiography in patients with an intermediate pretest likelihood for coronary artery disease.
    Dorenkamp M; Bonaventura K; Sohns C; Becker CR; Leber AW
    Heart; 2012 Mar; 98(6):460-7. PubMed ID: 21846767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relations between digital thermal monitoring of vascular function, the Framingham risk score, and coronary artery calcium score.
    Ahmadi N; Hajsadeghi F; Gul K; Vane J; Usman N; Flores F; Nasir K; Hecht H; Naghavi M; Budoff M
    J Cardiovasc Comput Tomogr; 2008 Nov; 2(6):382-8. PubMed ID: 19083982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
    Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized automated apolipoprotein A-I assays as markers for coronary artery disease.
    Levinson SS; Hobbs GA
    Arch Pathol Lab Med; 1997 Jul; 121(7):678-84. PubMed ID: 9240901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.
    Kavousi M; Elias-Smale S; Rutten JH; Leening MJ; Vliegenthart R; Verwoert GC; Krestin GP; Oudkerk M; de Maat MP; Leebeek FW; Mattace-Raso FU; Lindemans J; Hofman A; Steyerberg EW; van der Lugt A; van den Meiracker AH; Witteman JC
    Ann Intern Med; 2012 Mar; 156(6):438-44. PubMed ID: 22431676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of better iron status biomarkers and coronary artery disease risk.
    Zhou Y; Liu T; Kang P; Jia C
    Intern Med J; 2014 Sep; 44(9):846-50. PubMed ID: 24942316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities in coronary function and myocardial deformation between psoriasis and coronary artery disease: the role of oxidative stress and inflammation.
    Ikonomidis I; Makavos G; Papadavid E; Varoudi M; Andreadou I; Gravanis K; Theodoropoulos K; Pavlidis G; Triantafyllidi H; Parissis J; Paraskevaidis I; Rigopoulos D; Lekakis J
    Can J Cardiol; 2015 Mar; 31(3):287-95. PubMed ID: 25660150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-I, apolipoprotein B, high-sensitivity C-reactive protein and severity of coronary artery disease in Tunisian population.
    Hrira MY; Kerkeni M; Hamda BK; Chahed H; Ferchichi S; Addad F; Limam HB; Miled A
    Cardiovasc Pathol; 2012; 21(6):455-60. PubMed ID: 22425626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular opacification for the diagnosis of coronary artery disease with stress echocardiography: an angiographic study of incremental benefit and cost-effectiveness.
    Moir S; Shaw L; Haluska B; Jenkins C; Marwick TH
    Am Heart J; 2007 Sep; 154(3):510-8. PubMed ID: 17719299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort.
    Lee KW; Hill JS; Walley KR; Frohlich JJ
    CMAJ; 2006 Feb; 174(4):461-6. PubMed ID: 16477056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease.
    Berezin AE; Kremzer AA
    Atherosclerosis; 2013 Aug; 229(2):475-81. PubMed ID: 23880208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between Framingham risk categories and the presence of functionally relevant coronary lesions as determined on multislice computed tomography and stress testing.
    Nucifora G; Schuijf JD; van Werkhoven JM; Djaberi R; van der Wall EE; de Roos A; Scholte AJ; Schalij MJ; Jukema JW; Bax JJ
    Am J Cardiol; 2009 Sep; 104(6):758-63. PubMed ID: 19733707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of claims of improved prediction beyond the Framingham risk score.
    Tzoulaki I; Liberopoulos G; Ioannidis JP
    JAMA; 2009 Dec; 302(21):2345-52. PubMed ID: 19952321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening coronary arteriography in the primary prevention of coronary artery disease.
    Gandelman G; Bodenheimer MM
    Heart Dis; 2003; 5(5):335-44. PubMed ID: 14503931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of superoxide dismutase copper/zinc type and prognosis in a cohort of patients with coronary artery disease.
    Zengin E; Sinning C; Zeller T; Rupprecht HJ; Schnabel RB; Lackner KJ; Blankenberg S; Westermann D; Bickel C
    Biomark Med; 2015; 9(6):597-604. PubMed ID: 26079963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.